Open Access Email this article to a friend

Comparative injection-site pain and tolerability of subcutaneous serum-free formulation of interferonβ-1a versus subcutaneous interferonβ-1b: results of the randomized, multicenter, Phase IIIb REFORMS study

Barry Singer*, Daniel Bandari, Mark Cascione, Christopher LaGanke, John Huddlestone, Randy Bennett, Fernando Dangond and REFORMS Study Group

BMC Neurology 2012, 12:154 doi:10.1186/1471-2377-12-154

Fields marked * are required


Multiple email addresses should be separated with commas or semicolons.
How can I ensure that I receive BMC Neurology's emails?